Amgen: all 1,085 studies

Page 6 of 11. Open to participants first (51), then studies with results posted, then the rest; newest registration first within each.

• Effect of Panitumumab on the Pharmacokinetics of IrinotecanCompletedNCT00563316Phase 1Results posted
• Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)CompletedNCT00560794Phase 2Results posted
• Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor TherapyCompletedNCT00556374Phase 3Results posted
• Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle DisordersCompletedNCT00551200Phase 2Results posted
• Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT00547157Phase 2Results posted
• Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaCompletedNCT00531284Phase 1/2Results posted
• Phase 2 Study of Carfilzomib in Relapsed Multiple MyelomaCompletedNCT00530816Phase 2Results posted
• Extension Study to Evaluate the Long Term Safety and Efficacy of Denosumab in the Treatment of OsteoporosisCompletedNCT00523341Phase 3Results posted
• Apremilast Safety and PK Study in Recalcitrant Plaque PsoriasisCompletedNCT00521339Phase 2Results posted
• Denosumab Adherence Preference Satisfaction StudyCompletedNCT00518531Phase 3Results posted
• A Multi-Center, Randomized, Open-Label Study to Assess the Immunogenicity and Safety of Denosumab in Pre-filled Syringe Compared to Vial in Subjects With Low Bone Mineral DensityCompletedNCT00515463Phase 3Results posted
• Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric SubjectsCompletedNCT00515203Phase 1/2Results posted
• Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple MyelomaCompletedNCT00511238Phase 2Results posted
• An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITPCompletedNCT00508820Phase 3Results posted
• Panitumumab Plus FOLFIRI in First-line Treatment of Metastatic Colorectal CancerCompletedNCT00508404Phase 2Results posted
• Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck CancerCompletedNCT00500760Phase 2Results posted
• Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)CompletedNCT00472290Not applicableResults posted
• Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00460265Phase 3Results posted
• Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic ArthritisCompletedNCT00456092Phase 2Results posted
• Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT00454857Results posted
• PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of ResponseCompletedNCT00454779Phase 2Results posted
• Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated UlcersCompletedNCT00450658Phase 3Results posted
• Efficacy and Safety Study of HZT-501 in Subjects Requiring Nonsteroidal Anti-Inflammatory Drug (NSAID) TreatmentCompletedNCT00450216Phase 3Results posted
• PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)CompletedNCT00446446Phase 2Results posted
• Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney DiseaseTerminatedNCT00436748Phase 3Results posted
• A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)CompletedNCT00431496Phase 4Results posted
• SPIRITT - Second-Line Panitumumab Irinotecan Treatment TrialCompletedNCT00418938Phase 2Results posted
• A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving RevlimidCompletedNCT00418665Phase 2Results posted
• Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic PurpuraCompletedNCT00415532Phase 3Results posted
• Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00413283Phase 2Results posted
• Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to TreatmentCompletedNCT00411450Phase 2Results posted
• Talimogene Laherparepvec in Patients With Unresectable Pancreatic CancerCompletedNCT00402025Phase 1Results posted
• Darbepoetin Alfa With or Without Intravenous (IV) IronCompletedNCT00401544Phase 2Results posted
• Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of BoneCompletedNCT00396279Phase 2Results posted
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving HemodialysisCompletedNCT00379899Phase 4Results posted
• Study of Transitioning From Alendronate to DenosumabCompletedNCT00377819Phase 3Results posted
• STIMULATE Study: Anemia Correction and Health-related Quality of Life (HRQoL) Outcomes in Elderly Chronic Kidney Disease (CKD) PatientsTerminatedNCT00364845Phase 3Results posted
• PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine EfficacyCompletedNCT00364013Phase 3Results posted
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid ArthritisCompletedNCT00361634Phase 1Results posted
• RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialCompletedNCT00358215Phase 3Results posted
• Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical TrialsCompletedNCT00357903Phase 3Results posted
• Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012CompletedNCT00356590Phase 3Results posted
• E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular EventsCompletedNCT00345839Phase 3Results posted
• Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy AloneCompletedNCT00339183Phase 3Results posted
• Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in PsoriasisCompletedNCT00332332Phase 4Results posted
• Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based TherapyCompletedNCT00332163Phase 2Results posted
• Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.CompletedNCT00330759Phase 3Results posted
• A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.CompletedNCT00330460Phase 3Results posted
• An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00325468Phase 3Results posted
• Observational Safety Study of Etanercept (Enbrel) for Treatment of PsoriasisCompletedNCT00322439Results posted
• Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating AgentsCompletedNCT00321711Phase 2Results posted
• Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Men With Hormone-refractory Prostate CancerCompletedNCT00321620Phase 3Results posted
• A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects.CompletedNCT00321464Phase 3Results posted
• A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic SubjectsCompletedNCT00306189Phase 2Results posted
• Determination of Safe Dose of Romiplostim (AMG 531) in Patients With Myelodysplastic Syndromes (MDS)CompletedNCT00303472Phase 2Results posted
• A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00293813Phase 2Results posted
• A Study of Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant MelanomaCompletedNCT00289016Phase 2Results posted
• Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate CancerCompletedNCT00286091Phase 3Results posted
• A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With LymphomaCompletedNCT00283439Phase 1/2Results posted
• Safety Study of the Bispecific T-cell Engager Blinatumomab (MT103) in Patients With Relapsed NHLCompletedNCT00274742Phase 1Results posted
• Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal DiseaseCompletedNCT00261950Phase 2Results posted
• Open-Label, Phase 2, Proof of Concept Study in Multiple Myeloma - DenosumabCompletedNCT00259740Phase 2Results posted
• Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological MalignanciesCompletedNCT00150462Phase 1Results posted
• Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque PsoriasisCompletedNCT00141921Phase 3Results posted
• REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)CompletedNCT00127842Phase 4Results posted
• Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)CompletedNCT00117143Phase 1/2Results posted
• Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)CompletedNCT00116688Phase 3Results posted
• Organization of Teratology Information Services (OTIS) Autoimmune Diseases in Pregnancy ProjectCompletedNCT00116272Results posted
• PACCE: Panitumumab Advanced Colorectal Cancer Evaluation StudyCompletedNCT00115765Phase 3Results posted
• Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal CancerCompletedNCT00113763Phase 3Results posted
• Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal CancerCompletedNCT00111761Phase 2Results posted
• Evaluating the Safety and Efficacy of Romiplostim (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)CompletedNCT00111475Phase 2Results posted
• A Research Study for Patients With End-Stage Renal Disease (ESRD)CompletedNCT00110890Phase 4Results posted
• Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) BisphosphonatesCompletedNCT00104650Phase 2Results posted
• Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced CancerTerminatedNCT00101907Phase 1Results posted
• Efficacy, Safety and Tolerability of Denosumab in the Treatment of Rheumatoid ArthritisCompletedNCT00095498Phase 2Results posted
• Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00094835Phase 1/2Results posted
• Chemotherapy Administered Every 2 Weeks With or Without Pegfilgrastim in Subjects With Advanced or Metastatic Colon CancerCompletedNCT00094809Phase 2Results posted
• Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)CompletedNCT00093015Phase 3Results posted
• Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast CancerCompletedNCT00091832Phase 2Results posted
• Study to Evaluate AMG 162 in the Prevention of Postmenopausal OsteoporosisCompletedNCT00091793Phase 3Results posted
• A Study to Evaluate Denosumab in the Treatment of Postmenopausal OsteoporosisCompletedNCT00089791Phase 3Results posted
• AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate CancerCompletedNCT00089674Phase 3Results posted
• AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast CancerCompletedNCT00089661Phase 3Results posted
• Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal CancerCompletedNCT00089635Phase 2Results posted
• Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin ChemotherapyCompletedNCT00083616Phase 2Results posted
• Etanercept (Enbrel®) in Psoriasis - PediatricsCompletedNCT00078819Phase 3Results posted
• Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid ArthritisTerminatedNCT00078806Phase 3Results posted
• Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral DensityCompletedNCT00043186Phase 2Results posted
• Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency PatientsCompletedNCT00042432Phase 2Results posted
• A Trial to Assess Bioavailability of AMG 133 in Participants With Overweight or ObesityCompletedNCT07717814Phase 1
• Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose.CompletedNCT07545226Phase 1
• Effect of Maridebart Cafraglutide on How Oral Contraceptives Are Absorbed and Processed in the Body in Postmenopausal Female Participants Living With Overweight or ObesityActive, not recruitingNCT07523711Phase 1
• A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or OverweightActive, not recruitingNCT07441252Phase 2
• A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the BodyCompletedNCT07429045Phase 1
• The Effect of AMG 133 on Gastric EmptyingCompletedNCT07429032Phase 1
• A Study to Evaluate AMG 133 in Participants With Varying Degrees of Hepatic Impairment or Normal Hepatic FunctionCompletedNCT07428525Phase 1
• Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous DoseCompletedNCT07422285Phase 1
• A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous PresentationsCompletedNCT07313761Phase 1
• A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or ObesityCompletedNCT07310563Phase 1

← Amgen overview and focus areas